Abstract
Background
To explore the demographic and clinical features of current depressive episode that discriminate patients diagnosed with major depressive disorder (MDD) from those with bipolar I (BP-I) and bipolar II (BP-II) disorder who were misdiagnosed as having MDD .
Methods
The Mini-International Neuropsychiatric Interview (MINI) assessment was performed to establish DSM-IV diagnoses of MDD, and BP-I and BP-II, previously being misdiagnosed as MDD. Demographics, depressive symptoms and psychiatric comorbidities were compared between 1463 patients with BP-I, BP-II and MDD from 8 psychiatric settings in mainland China. A multinomial logistic regression model was performed to assess clinical correlates of diagnoses.
Results
A total of 14.5% of the enrolled patients initially diagnosed with MDD were eventually diagnosed with BP. Broad illness characteristics including younger age, higher prevalence of recurrence, concurrent dysthymia, suicidal attempts, agitation, psychotic features and psychiatric comorbidities, as well as lower prevalence of insomnia, weight loss and somatic symptoms were featured by patients with BP-I and/or BP-I, compared to those with MDD. Comparisons between BP-I and BP-II versus MDD indicated distinct symptom profiles and comorbidity patterns with more differences being observed between BP-II and MDD, than between BP-I and MDD .
Conclusion
The results provide evidence of clinically distinguishing characteristics between misdiagnosed BP-I and BP- II versus MDD. The findings have implications for guiding more accurate diagnoses of bipolar disorders.
Similar content being viewed by others
Background
Misdiagnosis of bipolar disorder (BP) is common in psychiatry clinics, with at least 20.8 − 61.5% of patients with BP being mistakenly diagnosed as having major depressive disorder (MDD) [1,20]. Further research with the inclusion of more somatic symptoms is needed to test whether patients with either subtype of BP are less physically vulnerable during depressive phases than those with MDD.
Regarding psychiatric comorbidities, each of the two groups of BP cases had significantly higher prevalence than MDD cases of the majority of the tested comorbidities. Specifically, all four forms of anxiety disorders, as well as OCD and eating disorders co-occurred more frequently in BP-II than in MDD, and three (current and lifetime panic disorders, agoraphobia without panic and antisocial personality disorder) of the nine tested comorbidities were more likely to be endorsed by BP-I cases than MDD cases. Overall, in contrast to the BP-I and MDD comparisons, there were more salient differences in comorbidity patterns between BP-II and MDD. This is consistent with previous findings by Angst et al. [42], but differs from other studies reporting either few differences in comorbidities between BP-I and BP-II versus MDD [12] or higher prevalence of comorbid anxiety disorders in BP-I than MDD and BP-II patients [9]. In addition to its high prevalence, comorbid anxiety in BP contributes to adverse illness course, poorer functioning and lower life quality and raises challenges in pharmacological treatment [43]. However, there has been no increase in research interest in this topic over the last two decades, and important issues such as the conceptualization, etiology of anxiety in BP and treatment (in particular, psychological therapy) for anxiety in patients with BP are still under-researched [43]. Future studies on this topic are needed.
In the multivariate logistic regression using MDD as the reference diagnosis, several predictors were significantly associated with BP diagnoses. Some associations (recurrence, antisocial personality disorder and absence of weight loss) were non-specific to BP subtypes and others were specific to BP-I (male gender, suicide attempt and panic disorder) or BP-II (less illness severity, psychotic features, concurrent agoraphobia without panic, and absence of terminal insomnia and somatic anxiety). Previously reported predictors of BP diagnoses based on multivariate regression analysis included more episodes being characteristic of BP-I [2, 12], psychotic features being characteristic of BP-I and BP-II [2] or BP-I [11, 12], mixed features being characteristic of BP-II [11, 12], anxiety disorders being characteristic of BP-I [9] or BP-II [42], and any personality disorder being characteristic of BP-I and BP-II [9], with a few of them being replicated in the present analyses. Despite findings from previous studies and ours using the multivariate regression models for discriminating between BP and MDD diagnoses, synthesis of findings is limited by the use of different definitions of variables, assessment instruments and comparison groups across studies.
Strengths and limitations
The strengths of this study include the large sample size, broad inclusion criteria and minimal exclusion criteria, as well as use of a structured diagnostic interview applied by well trained psychiatrists to obtain a more accurate diagnostic picture. There are a number of limitations. First, in this post-hoc analysis based on data from screening stages of a published clinical trial, the study sample is not representative of the overall naturalistic clinical population as patients who had already had a diagnosis of bipolar disorder before the start of this study and those who met criteria for bipolar disorder as judged by research psychiatrists at the first screening stage were excluded. That said we could only enroll participants with undiagnosed BP who were actually misdiagnosed as MDD. However, misclassification bias in this analysis should be small according to the stringent diagnostic assessment and this may provide an opportunity for clinicians to better understand the facets of bipolar depression that are extremely difficult to differentiate from MDD. Second, a causal relationship between clinical features and diagnoses cannot be determined due to the cross-sectional nature of the study. Third, the sample size of the BP-I group was relative small and prevalence of some comorbid conditions was relatively low, which might lower the statistical power of comparisons. Fourth, information like age at onset, family history of mental illness, number of episodes, mixed features and response to antidepressants (e.g. treatment resistance and antidepressant-induced agitated, anxious, mixed, or manic/hypomanic state), which may be potential distinguishers between diagnoses were not collected. Finally, the potential influence of current treatment for patients who were not medication-naïve on clinical presentation cannot be ruled out. Furthermore, the fact that few patients with BP were taking psychotropic medications limited our ability to compare medication use between groups or to explore potential associations between medication use and diagnosis.
Conclusion
Our results provide supportive evidence that symptom profiles and comorbidity patterns differ significantly between misdiagnosed bipolar I and bipolar II versus MDD, with more complex clinical differences existing between BP-II and MDD in contrast to the BP-I and MDD comparisons. This has implications for improving diagnostic decision making by identifying potential distinguishers of the two bipolar subtypes from MDD.
Given that our diagnoses were based on DSM-IV TR which have now been updated, future research based on the DSM-5 and/or ICD-11 could focus on: misdiagnosis or overdiagnosis of bipolar disorder in real-world clinical settings, implications of DSM-5/ICD-11 changes in diagnostic criteria for bipolar disorder on diagnostic prevalence of this illness, clinical presentation of depressive episodes of bipolar disorder and bipolar spectrum disorder compared to MDD, predictors of conversion from unipolar depression to bipolar disorder, strategies for improving accurate diagnosis of bipolar disorder in routine clinical practice, as well as the etiology and treatment for psychiatric comorbidities (e.g. anxiety disorders) in bipolar disorder.
Data availability
The datasets generated for this study are available on request to the corresponding author.
Abbreviations
- AGTs-MDD:
-
The Algorithm Guided Treatment Strategies for Major Depressive Disorder
- BP-I:
-
Bipolar I disorder
- BP-II:
-
Bipolar II disorder
- BP:
-
Bipolar disorder
- HRSD-17:
-
The 17-Item Hamilton Rating Scale for Depression
- MDD:
-
Major depressive disorder
- MINI:
-
The Chinese version Mini-International Neuropsychiatric Interview
- OCD:
-
Obsessive-compulsive disorder
- PTSD:
-
Post-traumatic stress disorder
References
Vohringer PA, Perlis RH. Discriminating between bipolar disorder and major depressive disorder. Psychiatr Clin North Am. 2016;39(1):1–10.
**ang YT, Zhang L, Wang G, Hu C, Ungvari GS, Dickerson FB, et al. Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China. Bipolar Disord. 2013;15(2):199–205.
Hu C, **ang YT, Ungvari GS, Dickerson FB, Kilbourne AM, Si TM, et al. Undiagnosed bipolar disorder in patients treated for major depression in China. J Affect Disord. 2012;140(2):181–6.
Altamura AC, Buoli M, Caldiroli A, Caron L, Cumerlato Melter C, Dobrea C, et al. Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: a naturalistic study. J Affect Disord. 2015;182:70–5.
**ang YT, Hu C, Wang G, Zheng QW, Fang YR, Ungvari GS, et al. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China. Hum Psychopharmacol. 2012;27(6):626–31.
Nierenberg AA, Agustini B, Kohler-Forsberg O, Cusin C, Katz D, Sylvia LG, et al. Diagnosis and treatment of bipolar disorder: a review. JAMA. 2023;330(14):1370–80.
Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003;60(3):261–9.
Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530–7.
Moreno C, Hasin DS, Arango C, Oquendo MA, Vieta E, Liu S, et al. Depression in bipolar disorder versus major depressive disorder: results from the national epidemiologic survey on alcohol and related conditions. Bipolar Disord. 2012;14(3):271–82.
Serretti A, Chiesa A, Calati R, Linotte S, Sentissi O, Papageorgiou K, et al. Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin NeuroSci. 2013;263(2):93–103.
Frankland A, Cerrillo E, Hadzi-Pavlovic D, Roberts G, Wright A, Loo CK, et al. Comparing the phenomenology of depressive episodes in bipolar I and II disorder and major depressive disorder within bipolar disorder pedigrees. J Clin Psychiatry. 2015;76(1):32–8. quiz 39.
Leonpacher AK, Liebers D, Pirooznia M, Jancic D, MacKinnon DF, Mondimore FM, et al. Distinguishing bipolar from unipolar depression: the importance of clinical symptoms and illness features. Psychol Med. 2015;45(11):2437–46.
Holma KM, Haukka J, Suominen K, Valtonen HM, Mantere O, Melartin TK, et al. Differences in incidence of suicide attempts between bipolar I and II disorders and major depressive disorder. Bipolar Disord. 2014;16(6):652–61.
Malhi GS, Outhred T, Irwin L. Bipolar II disorder is a myth. Can J Psychiatry. 2019;64(8):531–6.
Nierenberg AA. Bipolar II disorder is NOT a myth. Can J Psychiatry. 2019;64(8):537–40.
Gitlin M, Malhi GS. The existential crisis of bipolar II disorder. Int J Bipolar Disorders. 2020;8(1):5.
Karanti A, Kardell M, Joas E, Runeson B, Palsson E, Landen M. Characteristics of bipolar I and II disorder: a study of 8766 individuals. Bipolar Disord. 2020;22(4):392–400.
Benazzi F. Is there a continuity between bipolar and depressive disorders? Psychother Psychosom. 2007;76(2):70–6.
Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–24.
Wang Z, Jun C, Gao K, Yang H, Fang Y. Perspective on etiology and treatment of bipolar disorders in China: clinical implications and future directions. Neurosci Bull. 2019;35(4):608–12.
Xu Z, Gahr M, **ang Y, Kingdon D, Rusch N, Wang G. The state of mental health care in China. Asian J Psychiatr. 2022;69:102975.
Wang Z, Gao K, Hong W, **ng M, Wu Z, Chen J, et al. Guidelines disconcordance in acute bipolar depression: data from the national bipolar mania pathway survey (BIPAS) in mainland China. PLoS ONE. 2014;9(4):e96096.
Wang Z, Chen J, Zhang C, Gao K, Hong W, **ng M, et al. Guidelines concordance of maintenance treatment in euthymic patients with bipolar disorder: data from the national bipolar mania pathway survey (BIPAS) in mainland China. J Affect Disord. 2015;182:101–5.
Zhang H, Wu Z, Cao L, Su Y, Wang F, Hong W, et al. Evaluating the efficacy and moderators of algorithm-guided antidepressant treatments of major depressive disorder. J Affect Disord. 2022;297:68–75.
Wu Z, Cao L, Peng D, Mellor D, Zhang C, Li H, et al. The clinical correlates of comorbid anxiety symptoms and syndromal anxiety in patients with major depressive disorder. Psychiatry Res. 2018;269:251–7.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–quiz3334.
Si T, Shu L, Dang W, Su Y, Chen J, Dong W, et al. Evaluation of the reliability and validity of Chinese version of the M.I.N.I.-International neuropsychiatric interview in patients with mental disorders. Chin Mental Health J. 2009;23(7):492–503. [in Chinese].
Fogelson DL, Kagan BL. Bipolar spectrum disorder masquerading as treatment resistant unipolar depression. CNS Spectr. 2022;27(1):4–6.
Hebbrecht K, Stuivenga M, Birkenhager T, van der Mast RC, Sabbe B, Giltay EJ. Symptom profile and clinical course of inpatients with unipolar versus bipolar depression. Neuropsychobiology. 2020;79(4–5):313–23.
McIntyre RS. Subthreshold hypomania affects half of patients with bipolar disorder presenting with depressive symptoms. Evid Based Ment Health. 2017;20(3):e14.
Zimmerman M, Chelminski I, Young D, Dalrymple K, Martinez JH. A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder. J Affect Disord. 2014;168:357–62.
Benazzi F. Symptoms of depression as possible markers of bipolar II disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(3):471–7.
Hantouche EG, Akiskal HS. Bipolar II vs. unipolar depression: psychopathologic differentiation by dimensional measures. J Affect Disord. 2005;84(2–3):127–32.
Patella AM, Jansen K, Cardoso TA, Souza LDM, Silva RAD, Coelho F. Clinical features of differential diagnosis between unipolar and bipolar depression in a drug-free sample of young adults. J Affect Disord. 2019;243:103–7.
Serretti A, Mandelli L, Lattuada E, Cusin C, Smeraldi E. Clinical and demographic features of mood disorder subtypes. Psychiatry Res. 2002;112(3):195–210.
Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord. 2010;12(1):1–9.
Perlis RH, Brown E, Baker RW, Nierenberg AA. Clinical features of bipolar depression versus major depressive disorder in large multicenter trials. Am J Psychiatry. 2006;163(2):225–31.
Zhao D, Wu Z, Zhang H, Mellor D, Ding L, Wu H, et al. Somatic symptoms vary in major depressive disorder in China. Compr Psychiatry. 2018;87:32–7.
Huang J, Cai Y, Su Y, Zhang M, Shi Y, Zhu N, et al. Gastrointestinal symptoms during depressive episodes in 3256 patients with major depressive disorders: findings from the NSSD. J Affect Disord. 2021;286:27–32.
Parker G, Gladstone G, Chee KT. Depression in the planet’s largest ethnic group: the Chinese. Am J Psychiatry. 2001;158(6):857–64.
Lee DT, Kleinman J, Kleinman A. Rethinking depression: an ethnographic study of the experiences of depression among Chinese. Harv Rev Psychiatry. 2007;15(1):1–8.
Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, et al. Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge study: validity and comorbidity. Eur Arch Psychiatry Clin Neurosci. 2013;263(8):663–73.
Couillard Larocque M, Fortin-Vidah G, Angers M, Garceau L, Gros L, Fournel I, et al. Anxiety in bipolar disorder: a review of publication trends. J Affect Disord. 2023;320:340–7.
Acknowledgements
The authors acknowledge the study participants and colleagues.
Funding
This work was supported by Foundation of Ministry of Science and Technology of the People’s Republic of China (2016YFC1307100; 2021ZD0200602), National Natural Science Foundation of China (U22A20305; 82271548) and Shanghai Yangpu District Health Commission Foundation (22YPZB10).
Author information
Authors and Affiliations
Contributions
Zhiguo Wu is credited with creation of the study concept and design, investigation, statistical analyses and drafting of the manuscript, and obtained funding. Jun Wang is credited with running of statistical analyses, drafting of the manuscript and critical revision of the manuscript for important intellectual content. Chen Zhang is credited with investigation and critical revision of the manuscript for important intellectual content. Daihui Peng is credited with investigation, study supervision and critical revision of the manuscript for important intellectual content. David Mellor is credited with writing-review and editing and critical revision of the manuscript for important intellectual content. Yanli Luo is credited with writing-review and critical revision of the manuscript for important intellectual content. Yiru Fang is credited with the conception with the study design, study supervision and critical revision of the manuscript for important intellectual content. All authors reviewed and approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
The study was approved by the Institutional Review Board of Shanghai Mental Health Center (IRB00002733-Shanghai Mental Health Center) and followed all relevant national and international ethical guidelines including the Declaration of Helsinki. Written informed consent was provided by each participant prior to study entry.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Wu, Z., Wang, J., Zhang, C. et al. Clinical distinctions in symptomatology and psychiatric comorbidities between misdiagnosed bipolar I and bipolar II disorder versus major depressive disorder. BMC Psychiatry 24, 352 (2024). https://doi.org/10.1186/s12888-024-05810-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12888-024-05810-3